Cite
HARVARD Citation
Mathis, S. et al. (2015). Comparison of cross‐platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy. Cytometry. 88 (2), pp. 101-109. [Online].